Related references
Note: Only part of the references are listed.Myelodyslastic syndrome with isolated 5q deletion (5q-syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis
Mario Cazzola
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
Benjamin L. Ebert et al.
NATURE (2008)
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
Teru Hideshima et al.
NATURE REVIEWS CANCER (2007)
Tumor microenvironment: The role of the tumor stroma in cancer
Hanchen Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia
Olga Blau et al.
EXPERIMENTAL HEMATOLOGY (2007)
Lenalidomide in the context of complex karyotype or interrupted treatment:: case reviews of del(5q) MDS patients with unexpected responses
Aristoteles A. N. Giagounidis et al.
ANNALS OF HEMATOLOGY (2007)
The tumour microenvironment as a target for chemoprevention
Adriana Albini et al.
NATURE REVIEWS CANCER (2007)
Myelodysplastic syndromes: the complexity of stem-cell diseases
Seth J. Corey et al.
NATURE REVIEWS CANCER (2007)
KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders:: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients
Andres C. Garcia-Montero et al.
BLOOD (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
The stromal component of the marrow microenvironment is not derived from the malignant clone in MDS
Aravind Ramakrishnan et al.
BLOOD (2006)
Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines
B Blanco et al.
BLOOD (2006)
Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas
K Ishiguro et al.
GUT (2006)
Myelodysplasic syndromes: A comprehensive review
DVT Catenacci et al.
BLOOD REVIEWS (2005)
Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro
V Soenen-Cornu et al.
ONCOGENE (2005)
Mesenchymal stem cells in myelodysplastic syndromes:: phenotypic and cytogenetic characterization
E Flores-Figueroa et al.
LEUKEMIA RESEARCH (2005)
Myelodysplastic syndromes: From pathogenesis and prognosis to treatment
P Fenaux
SEMINARS IN HEMATOLOGY (2004)
Pathobiology, classification, and diagnosis of myelodysplastic syndrome
GJ Mufti
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2004)
Friends or foes - Bipolar effects of the tumour stroma in cancer
MM Mueller et al.
NATURE REVIEWS CANCER (2004)
GEPAS:: a web-based resource for microarray gene expression data analysis
J Herrero et al.
NUCLEIC ACIDS RESEARCH (2003)
DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones
H Fiegler et al.
GENES CHROMOSOMES & CANCER (2003)
The World Health Organization (WHO) classification of the myeloid neoplasms
JW Vardiman et al.
BLOOD (2002)
Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation
JA Pérez-Simón et al.
LEUKEMIA (2002)
In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome
E Flores-Figueroa et al.
LEUKEMIA RESEARCH (2002)
Mapping and sequencing chromosome breakpoints
NP Carter
CYTOMETRY (2002)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)